BFM
ABEO icon

Boothbay Fund Management’s Abeona Therapeutics ABEO Stock Holding History

Boothbay Fund Management’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-18,600
Closed -$104K – 1360
2024
Q4 		$104K Buy
+18,600
New +$114K ﹤0.01% 1285
2024
Q2 		– Sell
-19,200
Closed -$139K – 1477
2024
Q1 		$139K Buy
+19,200
New +$122K ﹤0.01% 1379
2018
Q2 		– Sell
-14
Closed -$485K – 728
2018
Q1 		$485K Buy
+14
New +$5.2K 0.06% 332
2017
Q4 		– Sell
-49
Closed -$2.08M – 694
2017
Q3 		$2.08M Buy
+49
New +$13.2K 0.35% 74

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Boothbay Fund Management's ABEO Position: Q4 2025 in Review

Boothbay Fund Management sold out of Abeona Therapeutics (ABEO) in Q4 2025, closing a stake of 17,816 shares — an estimated $94.1K sold.

Boothbay Fund Management first reported a position in ABEO in Q4 2019 and held it in 10 quarters. The position peaked at $1.96M in Q1 2024. 104 funds tracked by Wall St. Rank hold ABEO as of Q4 2025.

  • Boothbay Fund Management reported no remaining Abeona Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Boothbay Fund Management sold 17,816 Abeona Therapeutics shares in Q4 2025, an estimated $94.1K.
  • Boothbay Fund Management first reported a position in Abeona Therapeutics in Q4 2019 and held it in 10 quarters.
  • Boothbay Fund Management's Abeona Therapeutics position peaked at $1.96M in Q1 2024.
  • 104 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q4 2025.

Based on Boothbay Fund Management's 13F filing for Q4 2025, filed 17 Feb 2026.